Gabapentin, a frequently prescribed neuropathic pain medication, is of interest in patients with GBM as gabapentin inhibits the synaptogenic protein thrombospondin-1 (TSP-1), a protein responsible for GBM integration with local neural circuitry [190]. The gene discussed is THBS1; the disease is glioblastoma.